Developmental Funds

摘要：在当前的赠款期间，CCSG发展基金已与 慈善基金，通过支持试点项目，促进新墨西哥州大学癌症中心的战略优先事项， 招聘3名新教员和1名特殊人口工作人员调查员Cosette Wheeler博士。这个 联合国排雷行动中心试点赠款方案旨在加强多学科和跨学科癌症的协作 研究；促进癌症中心共享资源的使用，为校外赠款生成初步数据 应用；支持早期研究人员发起的临床试验；为毕业生提供匹配支持 学生和博士后研究员。新墨西哥州大学以及我们联盟的所有联东综合团成员 合作伙伴(Lovelace呼吸研究所)有资格申请。所有的拨款决定都是由 CCSG高级领导层经过艾伦·汤姆金森博士组织的正式、严格的同行审查过程后， 在癌症中心研究管理局的支持下，基础研究副主任。结果 (出版物、授权、专利、临床试验)通过申请年度进展来跟踪试点拨款 在奖励终止后的5年内报告。自2015年以来，107笔试点赠款涉及50多个联合国排雷行动 会员已获奖。这笔719,625美元的投资来自CCSG发展基金和2,096,148美元 来自癌症中心的慈善基金在同行评议的期刊上发表了44篇文章，并获得了 一名初级教员获得NCI K07奖学金，11名NIH R01奖学金，两名NIH R21奖学金，一名NIH P01奖学金和16名奖学金 来自其他国家供资机构的直接费用返还260273.34亿美元(总费用44829820美元)。在……里面 此外，美国癌症协会机构研究助学金支持新教师指导的试点项目 建立以癌症为重点的研究职业，包括行为研究职业。在下一个授权期内， 我们建议使用CCSG发展基金：1)在以下确定的研究领域招聘教师 联东综合团高级领导；2)资助试点赠款，促进协作、多学科和跨学科 基于实验室的癌症研究，临床癌症研究，基于人群的癌症研究， 癌症健康差异，以及涉及学术-社区伙伴关系和 社区参与战略；3)支持特殊人群工作人员调查员Cosette Wheeler博士， 世卫组织将专注于全州、全国和全球癌症预防研究倡议的战略发展； 和4)支持一名临床工作人员调查员和一名早期临床调查员，他们将在 该中心临床活动的开发和实施，扩大了临床试验组合， 与联合国儿童基金会提供服务的患者人数相匹配，并增加临床试验的应计费用。

ABSTRACT: In the current grant period, CCSG Developmental Funds have been used in combination with philanthropic funds to promote the strategic priorities of the UNM Cancer Center by supporting pilot projects, the recruitment of 3 new faculty and a Special Populations Staff Investigator, Cosette Wheeler, PhD. The UNMCC pilot grant program was designed to; enhance collaborative multidisciplinary and transdisciplinary cancer research; promote the use of Cancer Center Shared Resources to generate preliminary data for extramural grant applications; support early phase, investigator-initiated clinical trials; provide matching support for graduate students and postdoctoral fellows. All UNMCC members at New Mexico Universities, as well as at our consortium partner (Lovelace Respiratory Research Institute) were eligible to apply. All funding decisions were made by the CCSG senior leadership after a formal, rigorous peer review process organized by Alan Tomkinson, PhD, Associate Director for Basic Research, with support from the Cancer Center Research Administration. Outcomes (publications, grants, patents, clinical trials) from the pilot grants are tracked by requesting annual progress reports for 5 years after the award has terminated. Since 2015, 107 pilot grants involving more than 50 UNMCC members have been awarded. This investment of $719,625 from CCSG Developmental funds and $2,096,148 from Cancer Center philanthropic funds resulted in 44 publications in peer-reviewed journals and the award of one NCI K07 grant to a junior faculty, 11 NIH R01 grants, two NIH R21 grants, one NIH P01 grant, and 16 grants from other national funding agencies, a return of $26,027,334 million in direct costs ($44,829,820 total costs). In addition, an American Cancer Society Institutional Research Grant supports mentored pilot projects by new faculty establishing cancer-focused research careers, including careers in behavioral research. In the next grant period, we are proposing to use CCSG Developmental funds to; 1) faculty recruitment in research areas identified by UNMCCC senior leadership; 2) fund pilot grants that promote collaborative multidisciplinary and interdisciplinary research in laboratory-based cancer research, clinical cancer research, population-based cancer research, cancer health disparities, and catchment area studies involving academic-community partnerships and community engagement strategies; 3) support a Special Populations Staff Investigator, Cosette Wheeler, PhD, who will focus on strategic development of statewide, national, and global cancer prevention research initiatives; and 4) support a Clinical Staff Investigator and an Early Stage Clinical Investigator who will in play key roles in the development and implementation of the Center’s clinical activity, expanding a portfolio of clinical trials that are matched to the patient population served by the UNMCCC and increasing clinical trial accrual.